경카테터 심장판막 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 기술별, 지역별, 부문 예측(2025-2030년)

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), By Technology (Self-Expanded), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

경카테터 심장판막 시장의 성장과 동향 :

Grand View Research, Inc.의 새로운 보고서에 따르면 세계 카테터 심장 판막 시장 규모는 2025년부터 2030년까지 15.7%의 연평균 복합 성장률(CAGR)을 기록하며, 2030년까지 130억 달러에 이를 것으로 예측됩니다.

이 제품은 정상적인 밸브 수술을 받을 수 없는 노인 환자에게만 승인되었기 때문에 현재 시장은 충분히 침투하지 못하고 있습니다. 만성 심혈관병의 유병률 증가, 경제 발전 증가, 상환 시나리오 개선, 신기술 신속 채용 등 개발 촉진요인은 예측 기간 동안 사용률을 크게 개선할 것으로 예상됩니다.

경카테터 심장판막 시장은 에드워즈 라이프 사이언시스, 메드트로닉, 세인트 쥬드, 보스턴 사이언티픽과 같은 주요 기업에 의한 연구 개발에 대한 지속적인 투자로 빠르게 진화하고 있습니다. SAPIEN 3경카테터 심장 및 TRINITY 밸브와 같은 기술적으로 고급 제품은 수술 합병증을 줄이고 환자의 컴플라이언스를 개선하도록 설계되었습니다. 예를 들어, TRINITY TAVI 시스템은 환자의 안전성과 치료 성적을 손상시키지 않으면서 장치를 쉽게 회수하고 재배치할 수 있습니다.

게다가 투자자들의 관심이 높아지고 유리한 제품 파이프라인, 신속한 규제 당국의 승인, 잠재적 신흥기업의 인수 경쟁 격화 등으로 시장은 강한 추풍을 받을 것으로 예상됩니다. 예를 들어, 골드만 색소폰에 의한 비너스 메드텍의 3,700만 달러의 자금 조달과 같은 시장에 주목할만한 투자가 있습니다. 시장 동향에 맞추어 보스턴 사이언티픽, 에드워드 생명과학, 메드트로닉 등 시장 진출 기업도 승모판 역류 및 삼첨판 교체 관리용 신제품을 개발하기 위해 투자를 늘리고 있습니다.

경카테터 심장판막 시장 : 분석 개요

• 경카테터 대동맥판막 부문은 2024년에 84.0%의 최대 시장 점유율을 차지했습니다. 시장은 경카테터 대동맥판막, 폐동맥판막, 승모판막으로 분류됩니다.
• 시장은 기술별로 풍선 확장형 경카테터 판막와 자기 확장형 경카테터 판막로 분류됩니다. 2024년에는 자체 확장형 경카테터 판막 분야가 66.5%의 최대 시장 점유율을 차지했습니다.
• 북미의 경카테터 심장판 시장은 2024년에 48.3% 시장 점유율을 차지해 세계를 지배했습니다.
• 아시아태평양의 경카테터 심장판막 시장은 라이프 스타일의 변화, 도시화, 노화로 심혈관 질환으로 진단되는 환자 수가 증가하고 있음을 배경으로 큰 성장을 이루고 있습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 경카테터 심장판막 시장 : 변동 요인·경향·범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련/부수시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 경카테터 심장판막 시장 : 분석 도구
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 경카테터 심장판막 시장 : 용도별 추정과 동향 분석

• 세계 경카테터 심장판막 시장 : 용도별 대시보드
• 세계 경카테터 심장판막 시장 : 용도별 변동 분석
• 세계의 경카테터 심장판막 시장(수익 베이스, 용도별)
• 경카테터 대동맥판막
• 경카테터 폐동맥판막
• 경카테터 승모판막

제5장 경카테터 심장판 시장 : 기술별 추정과 동향 분석

• 세계의 경카테터 심장판막 시장 : 기술별 대시보드
• 세계 경카테터 심장판막 시장 : 기술별 변동 분석
• 세계의 경카테터 심장판막 시장(수익 베이스, 기술별)
• 풍선 확장형 경카테터 판막
• 자기 확장형 경카테터 판막

제6장 경카테터 심장판 시장 : 지역별 추정과 동향 분석(용도별·기술별)

• 지역별 대시보드
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 기업/경쟁의 분류
• 벤더 상황
  • 주요 기업의 시장 점유율 분석(2024년)
  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edward Lifesciences
  • Jenavalve
  • Abbott(St. Jude Medical)
  • Symetis
  • ValveXchange, Inc

KTH

영문 목차

영문목차

Transcatheter Heart Valve Market Growth & Trends:

The global transcatheter heart valve market size is expected to reach USD 13.0 billion by 2030, registering a CAGR of 15.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period.

The transcatheter heart valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements.

Transcatheter Heart Valve Market Report Highlights:

• The transcatheter aortic valve segment holds the largest market share of 84.0% in 2024. The market is divided into transcatheter aortic, pulmonary, and mitral valves.
• The market is categorized by technology into balloon-expanded transcatheter valves and self-expanded transcatheter valves. In 2024, the self-expanded transcatheter valve segment held the largest market share of 66.5%.
• The North America transcatheter heart valve market dominated globally with a 48.3% market share in 2024, driven by advanced healthcare infrastructure, high awareness levels, and strong healthcare spending.
• The Asia Pacific transcatheter heart valve market is experiencing significant growth driven by an increasing number of patients diagnosed with cardiovascular diseases due to changing lifestyles, urbanization, and an aging population.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Technology
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Transcatheter Heart Valve Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Incidence of Heart Valve Diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Growing preference for minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of treatments
    • 3.2.2.2. Regulatory challenges and approval delays
• 3.3. Transcatheter Heart Valve Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Transcatheter Heart Valve Market: Application Estimates & Trend Analysis

• 4.1. Global Transcatheter Heart Valve Market: Application Dashboard
• 4.2. Global Transcatheter Heart Valve Market: Application Movement Analysis
• 4.3. Global Transcatheter Heart Valve Market by Application, Revenue
• 4.4. Transcatheter Aortic Valve
  • 4.4.1. Transcatheter aortic valve market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Transcatheter Pulmonary Valve
  • 4.5.1. Transcatheter pulmonary valve market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Transcatheter Mitral Valve
  • 4.6.1. Transcatheter mitral valve market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Heart Valve Market: Technology Estimates & Trend Analysis

• 5.1. Global Transcatheter Heart Valve Market: Technology Dashboard
• 5.2. Global Transcatheter Heart Valve Market: Technology Movement Analysis
• 5.3. Global Transcatheter Heart Valve Market Estimates and Forecasts, By Technology, Revenue (USD Million)
• 5.4. Balloon Expanded Transcatheter Valve
  • 5.4.1. Balloon Expanded Transcatheter Valve market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Self-Expanded Transcatheter Valve
  • 5.5.1. Self-Expanded Transcatheter Valve market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Transcatheter Heart Valve Market: Regional Estimates & Trend Analysis by Application and Technology

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Vendor Landscape
  • 7.2.1. Key company market share analysis, 2024
  • 7.2.2. Boston Scientific Corporation
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Bracco Group
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Braile Biomedica
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Direct Flow Medical
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Edward Lifesciences
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Jenavalve
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Abbott (St. Jude Medical)
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Symetis
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. ValveXchange, Inc
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives

관련자료